Low risk of recurrence following artesunate–Sulphadoxine–pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan

Low risk of recurrence following artesunate–Sulphadoxine–pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan

Abstract Background First-line schizontocidal treatment for uncomplicated malaria in the Republic of the Sudan is artesunate (total dose 12 mg/kg) plus Sulphadoxine/pyrimethamine (25/1.25 mg/kg) (AS/SP). Patients with Plasmodium vivax are also treated with 14 days primaquine (total dose 3.5 mg/kg) (...

Full description

Bibliographic Details
Main Authors: Muzamil Mahdi Abdel Hamid, Kamala Thriemer, Maha E. Elobied, Nouh S. Mahgoub, Salah A. Boshara, Hassan M. H. Elsafi, Suhaib A. Gumaa, Tassneem Hamid, Hanadi Abdelbagi, Hamid M. Basheir, Jutta Marfurt, Ingrid Chen, Roly Gosling, Ric N. Price, Benedikt Ley
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Malaria Journal
Online Access:http://link.springer.com/article/10.1186/s12936-018-2266-9

Internet

http://link.springer.com/article/10.1186/s12936-018-2266-9

Similar Items